1 Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potentia..
来源:MOL CANCER( P E 1476-4598 ) 发表时间: 2019/04
类型:期刊论文 为本人加分:6587.333009
2 Role of the NF kappa B-signaling pathway in cancer
来源:ONCOTARGETS THER( P 1178-6930 E ) 发表时间: 2018/01
类型:期刊论文 为本人加分:5401.651694
3 The roles of glucose metabolic reprogramming in chemo- and radio-resistance
来源:J EXP CLIN CANC RES( P E 1756-9966 ) 发表时间: 2019/05
类型:期刊论文 为本人加分:2697.665355
4 LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-kappa B activi..
来源:ONCOGENE( P 0950-9232 E 1476-5594 ) 发表时间: 2019/06
类型:期刊论文 为本人加分:2656.413063
5 TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related P..
来源:J EXP CLIN CANC RES( P E 1756-9966 ) 发表时间: 2019/02
类型:期刊论文 为本人加分:1863.505372
6 Exosomes in Nasopharyngeal Carcinoma
来源:J CANCER( P 1837-9664 E ) 发表时间: 2018/01
类型:期刊论文 为本人加分:1789.707609
7 Exosomal miRNAs in tumor microenvironment
来源:J EXP CLIN CANC RES( P E 1756-9966 ) 发表时间: 2020/04
类型:期刊论文 为本人加分:1718.580070
8 The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
来源:FRONT IMMUNOL( P 1664-3224 E ) 发表时间: 2020/04
类型:期刊论文 为本人加分:1636.379500
9 The cancer metabolic reprogramming and immune response
来源:MOL CANCER( P E 1476-4598 ) 发表时间: 2021/02
类型:期刊论文 为本人加分:1566.598467
10 AKT and ERK dual inhibitors: The way forward?
来源:CANCER LETT( P 0304-3835 E 1872-7980 ) 发表时间: 2019/01
类型:期刊论文 为本人加分:1532.117703